Ambu A/S (OTCMKTS:AMBBY – Get Free Report) was the recipient of a large growth in short interest in October. As of October 15th, there was short interest totalling 900 shares, a growth of 350.0% from the September 30th total of 200 shares. Based on an average daily trading volume, of 400 shares, the days-to-cover ratio is presently 2.3 days.
Ambu A/S Stock Performance
Shares of OTCMKTS:AMBBY remained flat at $18.28 during trading on Friday. Ambu A/S has a one year low of $9.45 and a one year high of $22.65. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.52 and a quick ratio of 1.51. The firm has a market capitalization of $4.30 billion and a PE ratio of 91.40. The stock has a 50-day moving average of $19.68 and a 200 day moving average of $18.90.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last announced its quarterly earnings data on Friday, August 30th. The company reported $0.07 EPS for the quarter. Ambu A/S had a net margin of 8.55% and a return on equity of 8.09%. The firm had revenue of $199.56 million during the quarter.
Ambu A/S Company Profile
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Read More
- Five stocks we like better than Ambu A/S
- Want to Profit on the Downtrend? Downtrends, Explained.
- Texas Roadhouse Stock Steering for New Highs This Year
- Technology Stocks Explained: Here’s What to Know About Tech
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Learn Technical Analysis Skills to Master the Stock Market
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.